16 12, 2019 M.Lucia Reale et. al., Be-TeaM: An Italian real-world observational study on second-line therapy for EGFR-mutated NSCLC patients Diatech Pharmacogenetics2019-12-16T16:06:13+01:00 Mehr erfahren